Cas no 133-67-5 (Trichlormethiazide)
Trichlormethiazide is a thiazide diuretic primarily used to manage hypertension and edema associated with conditions such as congestive heart failure, renal dysfunction, or liver cirrhosis. Its mechanism of action involves inhibiting the sodium-chloride symporter in the distal convoluted tubule, promoting natriuresis and diuresis. The compound exhibits a well-characterized pharmacokinetic profile, with rapid absorption and a duration of action suitable for once-daily dosing. Key advantages include its efficacy in reducing blood pressure, compatibility with combination therapies, and a well-established safety profile when used as directed. Trichlormethiazide is also noted for its cost-effectiveness in long-term treatment regimens. Proper monitoring of electrolytes is recommended during therapy.
Trichlormethiazide structure
Product Name:Trichlormethiazide
CAS No:133-67-5
MF:C8H8Cl3N3O4S2
MW:380.655816078186
MDL:MFCD00057315
CID:153603
PubChem ID:87577089
Update Time:2025-06-07
Trichlormethiazide Chemical and Physical Properties
Names and Identifiers
-
- Trichlormethiazide
- Hydrotrichlorothiazide
- Trichloromethiazide
- 2H-1,2,4-Benzothiadiazine-7-sulfonamide,6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide
- IDE-8 ≥98
- 3-Dichloromethyl-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
- 6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide
- 6-Chloro-3-dichloromethyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide
- Achletin,Diu-Hydrin,Triflumen
- Metahydrin
- Naqua
- Trichlorex
- 6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide (+/-)-
- NSC 61560
- 6-Chloro-3-(dichloromethyl)-3,4-dihydro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide
- Nakva
- Navis
- Nydor
- Flutra
- Natril
- Pluvex
- Diurese
- Esmarin
- Eurinol
- Trichlormetazid
- Achletin
- Trichlormethiazid
- Diu-Hydrin
- Chlopolidine
- Schebitran
- Intromene
- Gangesol
- Diuroral
- Aponorin
- Cretonin
- Triflumen
- Isestran
- Fluitran
- Diurazida
- Flurese
- Triclordiuride
- Tachionin
- Kubacron
- Tolcasone
- Carvacron
- Anistadin
- Triclormetiazide
- Trichloromethiadiazide
- Metatensin
- Trichlormas
- Trichlordiuride
- Triclormetiazida
- Ciba 7057-Su
- Salurin (wadel)
- Trich
- 6-Chloro-3-(dichloromethyl)3,4-dihydro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide
- NAQUIVAL COMPONENT TRICHLORMETHIAZIDE
- Trichlormethiazide Metahydrin Naqua Trichlorex
- SW197095-3
- TRICHLORMETHIAZIDE [USP-RS]
- Opera_ID_1588
- Trichlormethiazide, United States Pharmacopeia (USP) Reference Standard
- DTXCID803699
- METATENSIN COMPONENT TRICHLORMETHIAZIDE
- 6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
- KBioGR_000833
- Tox21_110421
- AB00052117_17
- 6-Chloro-3-(dichloromethyl)3,2,4-benzothiadiazine-1,1-dioxide
- SPECTRUM1500590
- NCGC00018302-03
- Q58C92TUN0
- NCIOpen2_007750
- T1318
- 6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
- Prestwick_1020
- Q2072745
- s1667
- Triclormetiazida (INN-Spanish)
- TRICHLORMETHIAZIDE [HSDB]
- BSPBio_002926
- Z1562203528
- TRICHLORMETHIAZIDE [USP MONOGRAPH]
- 3-Dichloromethylhydrochlorothiazide
- TRICHLORMETHIAZIDE [MI]
- Prestwick0_000825
- 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide, (+-)-
- NCGC00018302-08
- HMS2235K21
- Naqua (TN)
- MLS000028705
- 6-chloro-3-(dichloromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide
- 6-Chloro-3-(dichloromethyl)3,4-dihydro-7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide
- Naquasone
- HMS3371B09
- WLN: T66 BSWM EM DHJ DYGG HG ISZW
- 6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-thiadiazine-7-sulfonamide 1,1-dioxide
- 6-chloro-3-(dichloromethyl)-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamid
- 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide
- BRN 0629145
- AS-56976
- HSDB 3406
- 3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,2,4-benzothiadiazine-1,1-dioxide
- CHEBI:9683
- SPBio_000916
- (+/-)-6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE
- SBI-0051544.P002
- TRICHLORMETHIAZIDE COMPONENT OF METATENSIN
- MFCD00057315
- 133-67-5
- HMS2097F11
- 6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1??,2,4-benzothiadiazine-7-sulfonamide
- SMR000058712
- BRD-A28940325-001-15-8
- KBio2_001000
- TRICHLORMETHIAZIDE COMPONENT OF NAQUIVAL
- Spectrum3_001373
- A908323
- TRICHLORMETHIAZIDE (MART.)
- Spectrum4_000367
- TRICHLORMETHIAZIDE [INN]
- C07767
- Prestwick3_000825
- BSPBio_000749
- CAS-133-67-5
- HMS2090G08
- SR-01000000284
- TRICHLORMETHIAZIDE [ORANGE BOOK]
- NCGC00018302-02
- NS00009500
- 1ST10693
- KBio2_006136
- 2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE, 6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-, 1,1-DIOXIDE, (+/-)-
- SCHEMBL25492
- Triclormetiazide [DCIT]
- Trichlormethiazide [USP:INN:JAN]
- Spectrum2_000948
- IDI1_000366
- SR-01000000284-4
- HMS3714F11
- NCGC00089756-03
- NCGC00018302-07
- NSC757368
- DB01021
- NSC-61560
- Trichlormethiazide, >=98%
- HMS501C08
- Pharmakon1600-01500590
- Trichlormethiazidum (INN-Latin)
- TRICHLORMETHIAZIDE (USP-RS)
- 6-chloro-3-dichloromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
- TRICHLORMETHIAZIDE [MART.]
- TRICHLORMETHIAZIDE [JAN]
- 3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
- HMS3655I17
- Spectrum_000520
- DTXSID7023699
- 2H-1,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide
- UNII-Q58C92TUN0
- 3-Dichloromethyl-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide
- BPBio1_000825
- TRICHLORMETHIAZIDE [GREEN BOOK]
- DivK1c_000366
- NCGC00089756-02
- Trichlormethiazide (JP17/USP/INN)
- Prestwick1_000825
- 6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZO THIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE
- (+-)-6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
- 3-Dichloromethyl-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
- CHEMBL1054
- MLS001076545
- EINECS 205-118-8
- AB00052117
- LMJSLTNSBFUCMU-UHFFFAOYSA-N
- trichloromethiazide, 6
- GTPL7314
- NCGC00016398-01
- AKOS024374993
- SPBio_002670
- FT-0746865
- AB00052117-15
- BDBM26998
- D00658
- NCGC00018302-04
- TRICHLORMETHIAZIDE [WHO-DD]
- HMS2092O19
- HMS1570F11
- KBio1_000366
- Spectrum5_001074
- Triclormetiazide [Italian]
- C03AA06
- AB00052117_16
- BRD-A28940325-001-05-9
- KBio2_003568
- Q-201860
- SR-01000000284-2
- Trichlormethiazidum
- HY-B0235
- Tox21_110421_1
- Prestwick2_000825
- NINDS_000366
- NSC-757368
- NSC61560
- Trichlormethiazide (USP:INN:JAN)
- Trichlormethiazidum [INN-Latin]
- KBio3_002146
- (3RS)-6-Chloro-3-dichloromethyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
- CCG-212834
- C72338
- 6-Chloro-3-(dichloromethyl)-3,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide
- Triclormetiazida [INN-Spanish]
- Trichlormethiazide (Achletin)
- 6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide
- 3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,2,4-benzothiadiazine 1,1-dioxide
- TRICHLORMETHIAZIDE (USP MONOGRAPH)
- 6-Chloro-3-dichloromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide
- HMS1921G13
- KBioSS_001000
- TRICHLORMETHIAZIDE [VANDF]
- E6,2,4-benzothiadiazine-7-sulfonamide
- 6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1
- BRD-A28940325-001-24-0
- BRD-A28940325-001-23-2
- BRD-A28940325-001-25-7
-
- MDL: MFCD00057315
- Inchi: 1S/C8H8Cl3N3O4S2/c9-3-1-4-6(2-5(3)19(12,15)16)20(17,18)14-8(13-4)7(10)11/h1-2,7-8,13-14H,(H2,12,15,16)
- InChI Key: LMJSLTNSBFUCMU-UHFFFAOYSA-N
- SMILES: ClC(C1NC2C=C(C(=CC=2S(N1)(=O)=O)S(N)(=O)=O)Cl)Cl
Computed Properties
- Exact Mass: 378.90200
- Monoisotopic Mass: 378.902
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 20
- Rotatable Bond Count: 2
- Complexity: 571
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 0.6
- Topological Polar Surface Area: 135
Experimental Properties
- Density: 1.748
- Melting Point: 248-250 oC
- Boiling Point: 631.3°C at 760 mmHg
- Flash Point: 335.6°C
- Refractive Index: 1.6000 (estimate)
- PSA: 135.12000
- LogP: 4.14970
- Merck: 9624
Trichlormethiazide Security Information
-
Symbol:
- Signal Word:Danger
- Hazard Statement: H317-H334
- Warning Statement: P261-P280-P342+P311
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:2
- Hazard Category Code: 42/43
- Safety Instruction: S36
- RTECS:DK8925000
-
Hazardous Material Identification:
- Safety Term:S36
- Risk Phrases:R42/43
- Toxicity:LD50 orally in rats: >20000 mg/kg (Goldenthal)
- HazardClass:6.1
- PackingGroup:Ⅲ
- Storage Condition:4°C, protect from light
Trichlormethiazide Customs Data
- HS CODE:2935009090
- Customs Data:
China Customs Code:
2935009090Overview:
2935009090 Other sulphonates(Acyl)amine. VAT:17.0% Tax refund rate:9.0% Regulatory conditions:nothing MFN tariff:6.5% general tariff:35.0%
Declaration elements:
Product Name, component content, use to
Summary:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%
Trichlormethiazide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | T863687-5g |
Trichlormethiazide |
133-67-5 | ≥98% | 5g |
¥378.90 | 2022-08-31 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci6668-50mg |
Trichlormethiazide |
133-67-5 | 98% | 50mg |
¥592.00 | 2023-09-09 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T0114-500 mg |
Trichlormethiazide |
133-67-5 | 99.54% | 500MG |
¥395.00 | 2022-04-26 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T0114-1 g |
Trichlormethiazide |
133-67-5 | 99.54% | 1g |
¥485.00 | 2022-04-26 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T0114-1 mL * 10 mM (in DMSO) |
Trichlormethiazide |
133-67-5 | 99.54% | 1 mL * 10 mM (in DMSO) |
¥485.00 | 2022-04-26 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R022219-25g |
Trichlormethiazide |
133-67-5 | 98% | 25g |
¥1134 | 2024-05-26 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R022219-5g |
Trichlormethiazide |
133-67-5 | 98% | 5g |
¥365 | 2024-05-26 | |
| S e l l e c k ZHONG GUO | S1667-50mg |
Trichlormethiazide |
133-67-5 | 99.36% | 50mg |
¥814.51 | 2023-09-15 | |
| MedChemExpress | HY-B0235-10mM*1mLinDMSO |
Trichlormethiazide |
133-67-5 | 98.59% | 10mM*1mLinDMSO |
¥500 | 2023-07-26 | |
| MedChemExpress | HY-B0235-500mg |
Trichlormethiazide |
133-67-5 | 98.59% | 500mg |
¥400 | 2024-04-20 |
Trichlormethiazide Related Literature
-
1. Fluorination of trichlormethiazide with fluoroxytrifluoromethaneDerek H. R. Barton,Robert H. Hesse,Maurice M. Pechet,Hee T. Toh J. Chem. Soc. Perkin Trans. 1 1980 712
-
Cris Lapthorn,Frank S. Pullen,Babur Z. Chowdhry,Patricia Wright,George L. Perkins,Yanira Heredia Analyst 2015 140 6814
-
Chilukuri S. P. Sastry,Tata N. V. Prasad,Bhetanabhotla S. Sastry,Erraguntla Venkata Rao Analyst 1988 113 255
-
Myriam C. Salvadori,Mirtes E. Velletri,Márcia M. A. Camargo,Adélia C. P. Araújo Analyst 1988 113 1189
-
Myriam C. Salvadori,Mirtes E. Velletri,Márcia M. A. Camargo,Adélia C. P. Araújo Analyst 1988 113 1189
133-67-5 (Trichlormethiazide) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)
Recommended suppliers
Shenzhen Yaoyuan R&D Center Co.,Ltd
Gold Member
CN Supplier
Bulk
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
CN Supplier
Reagent
Amadis Chemical Company Limited
Gold Member
CN Supplier
Reagent
Jiangsu Kolod Food Ingredients Co.,ltd
Gold Member
CN Supplier
Bulk
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
CN Supplier
Reagent